Merck Drug Pricing Impact

Order byBest matchMost fresh

Trump, drug prices

Pharma stocks recover from initial shock of Trump's drug pricing order

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges.

· 21h

One estimate of the profit hit from Trump's executive order on drug pricing

· 1d

How will Donald Trump’s plan to cut drug prices work?

· 1d

Trump executive order demands pharma industry price cuts

China and the United States announced a truce in their trade war on Monday after talks in Geneva that will roll back the bulk of tariffs and other countermeasures by Wednesday.

· 1d

With No Real Policy, Trump Asks Drugmakers to Lower U.S. Prices

· 1d

Trump signs executive order seeking to lower US drug costs by challenging prices in other countries

· 12h

European governments scramble to interpret Trump's new drug pricing order

Two of Europe's major stock exchange operators are stepping up efforts to retain local initial public offerings in the face of U.S. competition, with marketing and research challenging the perception ...

The Economist · 23h

Big pharma’s jumbo profits are under threat in America

· 1d

The Latest: Trump signs executive order that gives drugmakers 30-day deadline to lower costs

3hon MSN

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen next.

1don MSN

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now

The pharmaceutical industry’s reaction to President Trump’s executive order on drug prices? It could have been worse.Shares of drugmakers surged Monday after President Trump signed an executive order designed to lower what Americans pay for prescription drugs that offered pharmaceutical companies room for negotiation.

Merck’s New Keytruda Shot Is a Rare Real-Time ‘Product Hop’ (1)

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, expand access, and save more lives, the company says. But by shifting patients to a version protected by newer patents,

Reuters6d

Merck & Co Inc

US court shuts down AstraZeneca's challenge to Medicare drug price ... on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. manufacturing. Merck to invest ...